Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2018 - 2026)
Biolife Solutions (BLFS) posted quarterly Non-Current Deferred Tax Liability of $198000.0 for Q1 2026, up 52.31% year-over-year from $130000.0 in Q1 2025, and up 4.76% quarter-over-quarter from $189000.0 in Q4 2025.
Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $198000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 52.31% year-over-year to $198000.0; the TTM figure through Mar 2026 stood at $198000.0 (up 52.31% YoY), while the FY2025 annual figure was $189000.0, down 96.2% from the prior year.
- Non-Current Deferred Tax Liability rose to $198000.0 in Q1 2026 per BLFS's latest filing, from $189000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $5.0 million in Q4 2024 and bottomed at $100000.0 in Q3 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $820529.4 across 5 years, with a median of $198000.0 in 2026.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability jumped 4268.42% — and 2025, when it sank 96.2%.
- Biolife Solutions' Non-Current Deferred Tax Liability stood at $250000.0 in 2022, then plunged by 54.4% to $114000.0 in 2023, then surged by 4268.42% to $5.0 million in 2024, then tumbled by 96.2% to $189000.0 in 2025, then rose by 4.76% to $198000.0 in 2026.
- Business Quant data shows BLFS's Non-Current Deferred Tax Liability at $198000.0 in Q1 2026, $189000.0 in Q4 2025, and $189000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198,000.00 |
| Mar 31, 2026 | 198,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 4.98 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |